PPG Industries R&D increased by 3.7% to $113.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.8%, from $102.00M to $113.00M. Over 4 years (FY 2021 to FY 2025), R&D shows relatively stable performance with a -0.9% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $107.00M | $114.00M | $116.00M | $115.00M | $115.00M | $110.00M | $94.00M | $104.00M | $110.00M | $108.00M | $102.00M | $107.00M | $108.00M | $102.00M | $106.00M | $102.00M | $106.00M | $106.00M | $109.00M | $113.00M |
| QoQ Change | — | +6.5% | +1.8% | -0.9% | +0.0% | -4.3% | -14.5% | +10.6% | +5.8% | -1.8% | -5.6% | +4.9% | +0.9% | -5.6% | +3.9% | -3.8% | +3.9% | +0.0% | +2.8% | +3.7% |
| YoY Change | — | — | — | — | +7.5% | -3.5% | -19.0% | -9.6% | -4.3% | -1.8% | +8.5% | +2.9% | -1.8% | -5.6% | +3.9% | -4.7% | -1.9% | +3.9% | +2.8% | +10.8% |